Yamaguchi F, Nasa Y, Yabe K, Ohba S, Hashizume Y, Ohaku H, Furuhama K, Takeo S
Department of Pharmacology, Tokyo University of Pharmacy and Life Science, Japan.
Heart Vessels. 1997;12(2):74-83. doi: 10.1007/BF02820870.
Activation of cardiac muscarinic receptors by vagal stimulation decreases cardiac work, which may have a protective effect against ischemic injury. To determine whether cardiac muscarinic receptors contribute to the mechanisms of preconditioning effects, we examined the effect of carbachol on ischemia/reperfusion damage and the effect of vagotomy on cardioprotection induced by ischemic preconditioning. Rats were subjected to 30 min of left coronary artery occlusion followed by 30-min reperfusion in situ. Pre-conditioning was induced by three cycles of 2-min coronary artery occlusion and, subsequently by 5 min of reperfusion. The incidence of ischemic arrhythmias, such as ventricular tachycardia (VT) and ventricular fibrillation (VF), and the development of myocardial infarction were markedly reduced by the preconditioning. Carbachol infusion (4 micrograms/kg per min) delayed the occurrence of VT and VF during ischemia and reduced the infarct size. Compared with non-ischemic left ventricle, the cyclic guanosine monophosphate (GMP) content in the ischemic region of the left ventricle was decreased by ischemia/reperfusion, whereas the cyclic adenosine monophosphate (AMP) content of this region was increased. These changes were reversed by preconditioning. Similar changes in cyclic GMP and AMP content in the ischemic region were seen in rats undergoing carbachol treatment. These results suggest the possible contribution of muscarinic receptor stimulation to preconditioning. Vagotomy prior to preconditioning diminished the antiarrhythmic effects, whereas it did not block the anti-infarct effect afforded by pre-conditioning. Vagotomy abolished the preconditioning effect on the tissue cyclic GMP, but it did not attenuate the decrease in tissue cyclic AMP. The results suggest that muscarinic stimulation exerts preconditioning-mimetic protective effects in ischemic/reperfused hearts, but that a contribution of reflective vagal activity to the mechanism for preconditioning is unlikely.
迷走神经刺激激活心脏毒蕈碱受体可降低心脏做功,这可能对缺血性损伤具有保护作用。为了确定心脏毒蕈碱受体是否参与预处理效应的机制,我们研究了卡巴胆碱对缺血/再灌注损伤的影响以及迷走神经切断术对缺血预处理诱导的心脏保护作用的影响。将大鼠左冠状动脉闭塞30分钟,然后在原位再灌注30分钟。预处理通过三个2分钟冠状动脉闭塞周期诱导,随后再灌注5分钟。预处理显著降低了缺血性心律失常(如室性心动过速和室性颤动)的发生率以及心肌梗死的发生。输注卡巴胆碱(4微克/千克/分钟)可延迟缺血期间室性心动过速和室性颤动的发生,并减小梗死面积。与非缺血左心室相比,缺血/再灌注使左心室缺血区域的环磷酸鸟苷(cGMP)含量降低,而该区域的环磷酸腺苷(cAMP)含量增加。预处理可逆转这些变化。接受卡巴胆碱治疗的大鼠缺血区域的cGMP和cAMP含量也出现类似变化。这些结果表明毒蕈碱受体刺激可能对预处理有作用。预处理前进行迷走神经切断术可减弱抗心律失常作用,但并未阻断预处理提供的抗梗死作用。迷走神经切断术消除了预处理对组织cGMP的作用,但并未减弱组织cAMP的降低。结果表明,毒蕈碱刺激在缺血/再灌注心脏中发挥类似预处理的保护作用,但迷走神经反射活动对预处理机制的贡献不太可能。